The Hye Young Lee Lab at UT Health San Antonio – a dynamic team leading cutting-edge gene therapy research for Fragile X syndrome using next-generation mRNA delivery systems.

Gene Therapeutic Development for Fragile X Syndrome

Dr. Lee’s team is testing novel gene editing therapies for Fragile X, aiming to repair FMR1 and restore the missing protein — a promising new strategy which is targeted and reversible.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (38)